Title: | Clinical Practice Guideline on Primary Central Nervous System Lymphoma |
Edition: | Original |
Classification: | Standard guideline |
Field: | Comprehensive guideline |
Countries and regions: | China |
Guidelines users: | Clinical professionals (including clinical practitioners, pharmacists and nurses) |
Evidence classification method: | Grading of Recommendations, Assessment, Development and Evaluations, GRADE |
Development unit: | The Chinese Neurosurgical Society of the Chinese Medical Association, The Society of Hematological malignancies of China Anti-Cancer Association |
Registration time: | 2021-01-01 |
Registration number: | IPGRP-2021CN001 |
Purpose of the guideline: | This guideline followed the standard method and process of developing an evidence-based clinical practice guideline, aims to standardize the diagnosis and treatment of primary central nervous system lymphoma, and provides the appropriate support for health workers and practitioners in the field of primary central nervous system lymphoma. |
Latest registration